| MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast … A Chamorro-Jorganes, E Araldi, LOF Penalva, D Sandhu, ... Arteriosclerosis, thrombosis, and vascular biology 31 (11), 2595-2606, 2011 | 291 | 2011 |
| Mir-33 regulates cell proliferation and cell cycle progression D Cirera-Salinas, M Pauta, RM Allen, AG Salerno, CM Ramírez, ... Cell cycle 11 (5), 922-933, 2012 | 192 | 2012 |
| VEGF-induced expression of miR-17–92 cluster in endothelial cells is mediated by ERK/ELK1 activation and regulates angiogenesis A Chamorro-Jorganes, MY Lee, E Araldi, S Landskroner-Eiger, ... Circulation research 118 (1), 38-47, 2016 | 171 | 2016 |
| A regulatory role for microRNA 33* in controlling lipid metabolism gene expression L Goedeke, FM Vales-Lara, M Fenstermaker, D Cirera-Salinas, ... Molecular and cellular biology 33 (11), 2339-2352, 2013 | 160 | 2013 |
| Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis LS Danielson, DS Park, N Rotllan, A Chamorro-Jorganes, MV Guijarro, ... The FASEB Journal 27 (4), 1460-1467, 2013 | 140 | 2013 |
| MicroRNAs as pharmacological targets in endothelial cell function and dysfunction A Chamorro-Jorganes, E Araldi, Y Suárez Pharmacological Research 75, 15-27, 2013 | 127 | 2013 |
| The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma A Esteve-Arenys, JG Valero, A Chamorro-Jorganes, D Gonzalez, ... Oncogene 37 (14), 1830, 2018 | 87 | 2018 |
| Improved repair of dermal wounds in mice lacking micro RNA‐155 C van Solingen, E Araldi, A Chamorro‐Jorganes, C Fernández‐Hernando, ... Journal of cellular and molecular medicine 18 (6), 1104-1112, 2014 | 72 | 2014 |
| Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cells A Chamorro-Jorganes, E Araldi, N Rotllan, D Cirera-Salinas, Y Suárez J Cell Sci 127 (6), 1169-1178, 2014 | 70 | 2014 |
| Therapeutic potential of modulating microRNAs in atherosclerotic vascular disease E Araldi, A Chamorro-Jorganes, C van Solingen, C Fernández-Hernando, ... Current vascular pharmacology 13 (3), 291-304, 2015 | 51 | 2015 |
| Bioinspired artificial exosomes based on lipid nanoparticles carrying let-7b-5p promote angiogenesis in vitro and in vivo S Aday, I Hazan-Halevy, A Chamorro-Jorganes, M Anwar, M Goldsmith, ... Molecular Therapy, 2021 | 49 | 2021 |
| BDNF (Brain-Derived Neurotrophic Factor) Promotes Embryonic Stem Cells Differentiation to Endothelial Cells Via a Molecular Pathway, Including MicroRNA-214, EZH2 (Enhancer of … B Descamps, J Saif, AV Benest, G Biglino, DO Bates, ... Arteriosclerosis, Thrombosis, and Vascular Biology 38 (9), 2117-2125, 2018 | 44 | 2018 |
| Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis N Rotllan, A Chamorro-Jorganes, E Araldi, AC Wanschel, B Aryal, ... The FASEB Journal 29 (2), 597-610, 2015 | 42 | 2015 |
| miR-15a/-16 inhibit angiogenesis by targeting the Tie2 coding sequence: therapeutic potential of a miR-15a/16 decoy system in limb ischemia M Besnier, S Shantikumar, M Anwar, P Dixit, A Chamorro-Jorganes, ... Molecular Therapy-Nucleic Acids 17, 49-62, 2019 | 37 | 2019 |
| Thrombospondin-2 regulates extracellular matrix production, LOX levels, and cross-linking via downregulation of miR-29 NE Calabro, A Barrett, A Chamorro-Jorganes, S Tam, NJ Kristofik, H Xing, ... Matrix Biology 82, 71-85, 2019 | 35 | 2019 |
| METTL3 Regulates Angiogenesis by Modulating let-7e-5p and miRNA-18a-5p Expression in Endothelial Cells A Chamorro-Jorganes, WK Sweaad, R Katare, M Besnier, M Anwar, ... Arteriosclerosis, Thrombosis, and Vascular Biology 41 (6), e325-e337, 2021 | 32 | 2021 |
| Targeted genomic disruption of H-Ras induces hypotension through a NO-cGMP-PKG pathway–dependent mechanism A Chamorro-Jorganes, MT Grande, B Herranz, M Jerkic, M Griera, ... Hypertension 56 (3), 484-489, 2010 | 19 | 2010 |
| Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma P Balsas, A Esteve-Arenys, J Roldán, L Jiménez, V Rodríguez, JG Valero, ... Journal of hematology & oncology 10 (1), 80, 2017 | 17 | 2017 |
| Fibronectin upregulates cGMP-dependent protein kinase type Iβ through C/EBP transcription factor activation in contractile cells A Chamorro-Jorganes, L Calleros, M Griera, M Saura, A Luengo, ... American Journal of Physiology-Cell Physiology 300 (3), C683-C691, 2011 | 12 | 2011 |
| Relevance of N6-methyladenosine regulators for transcriptome: Implications for development and the cardiovascular system WK Sweaad, FM Stefanizzi, A Chamorro-Jorganes, Y Devaux, ... Journal of Molecular and Cellular Cardiology, 2021 | 11 | 2021 |
